Invention Publication
- Patent Title: COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION
-
Application No.: US18289283Application Date: 2022-05-02
-
Publication No.: US20240252454A1Publication Date: 2024-08-01
- Inventor: Tim BERGBREDE , Raffaella DI LUCREZIA , Anke UNGER , Axel CHOIDAS , Bert KLEBL , Peter NUSSBAUMER , Sascha MENNINGER , Peter HABENBERGER , Gunther ZISCHINSKY , Uwe KOCH , Peter SCHRÖDER , Pavla JESTRABOVÁ , Lenka PALOVÁ-JELÍNKOVÁ , Klára DÁNOVÁ , Maria FALKENBERG-GUSTAFSSON , Laleh ARABANIAN , Claes GUSTAFSSON , Nils-Göran LARSSON , Lars PALMQVIST
- Applicant: LEAD DISCOVERY CENTER GMBH , MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
- Applicant Address: DE Dortmund
- Assignee: LEAD DISCOVERY CENTER GMBH,MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
- Current Assignee: LEAD DISCOVERY CENTER GMBH,MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
- Current Assignee Address: DE Dortmund
- Priority: EP 171865.5 2021.05.03
- International Application: PCT/EP2022/061705 2022.05.02
- Date entered country: 2023-11-02
- Main IPC: A61K31/166
- IPC: A61K31/166 ; A61K31/4184 ; A61K31/453 ; A61K31/47 ; A61K31/496 ; A61K31/5377 ; A61K31/711 ; A61P35/00
Abstract:
The present invention relates to a composition comprising at least one inhibitor of mitochondrial transcription (IMT) and at least one anti-cancer drug. Furthermore, the present invention is directed to compositions for use as a medicament and to compositions for use in the treatment and/or prevention of cancer.
Information query
